<ARTICLE> 5 <CIK> 0000942788 <NAME> NEOPHARM, INC. <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1996 <PERIOD-START> JUL-01-1996 <PERIOD-END> SEP-30-1996 <CASH> 4,893,691 <SECURITIES> 0 <RECEIVABLES> 0 <ALLOWANCES> 0 <INVENTORY> 0 <CURRENT-ASSETS> 4,893,691 <PP&E> 36,504 <DEPRECIATION> 25,384 <TOTAL-ASSETS> 4,904,811 <CURRENT-LIABILITIES> 83,945 <BONDS> 0 <COMMON> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 1,742 <OTHER-SE> 5,816,367 <TOTAL-LIABILITY-AND-EQUITY> 4,904,811 <SALES> 0 <TOTAL-REVENUES> 66,197 <CGS> 0 <TOTAL-COSTS> 0 <OTHER-EXPENSES> 369,699 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> (303,502) <INCOME-TAX> 0 <INCOME-CONTINUING> (303,502) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (303,502) <EPS-PRIMARY> (0.04) <EPS-DILUTED> 0